{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-004557","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2024-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.025489+00:00","generated_at":"2026-06-06T00:32:33.369228+00:00","sec_items":["3.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"GeoVax regains Nasdaq compliance after reverse stock split, delisting cancelled","bullets":["Received Nasdaq delisting notice Dec 6, 2023 for bid price below $1.00.","Effected 1-for-? reverse stock split on Jan 31, 2024; shares then traded above $1.00 for 10 consecutive days.","On Feb 16, 2024, Nasdaq confirmed compliance regained; hearing cancelled and listing maintained.","GeoVax common (GOVX) and warrants (GOVXW) continue trading on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-004557","json":"https://secwatch.observer/filing/0001437749-24-004557.json","markdown":"https://secwatch.observer/filing/0001437749-24-004557.md","text":"https://secwatch.observer/filing/0001437749-24-004557.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774924004557/0001437749-24-004557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774924004557/govx20240216_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T00:32:33.369228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1347983ae024ce3edebdc7a823d4eac34e64ebbd","claim":"GeoVax Labs, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"February 16, 2024, the Company received a letter from Nasdaq stating that Nasdaq has determined the Company to have regained compliance with The Nasdaq Capital Market listing requirements and that, consequently, the scheduled Hearing has been cancelled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924004557/0001437749-24-004557-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}